Business News • PR NewsWire • TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS

TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS

TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS

VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body's ability to self-repair and regenerate, today announced the publication in Frontiers in Phamacology of peer-reviewed research supporting the unique...

View More : https://www.prnewswire.com:443/news-releases/tikomeds-ilb-mobilizes-and-modulates-key-growth-factors-that-trigger-a-casc...

Releted News by prnewswire

Hemodialysis and Peritoneal Dialysis Market to Record a YoY Growth Rate of 4.29%, Asahi Kasei Corp. and B. Braun SE Among Key Vendors - Technavio

World Kickboxing Champion Milana Bjelogrlić becomes Reltime Global Web3 and Metaverse Ambassador

Online Jewelry Market to Record a 14.97% Y-O-Y Growth Rate in 2022, Increase in the Adoption of an Omnichannel Strategy to be a Major Trend - Technavio

TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS

HoverTouch™: First AI and Computer Vision Solution launched by Spacee that Transforms Existing Retail Surfaces Into Interactive Customer Experiences

Global Esports Federation and Panam Sports Establish Pan American Esports Championships